Basics Xeris Pharmaceuticals, Inc. IPO Date: June 22, 2018 Sector: Healthcare Market Cap: $1.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.39% Avg Daily Range (30 D): $0.17 | 2.14% Avg Daily Range (90 D): $0.13 | 1.99% Institutional Daily Volume Avg Daily Volume: 1.44M Avg Daily Volume (30 D): 1.85M Avg Daily Volume (90 D): 1.95M Trade Size Avg Trade Size (Sh.): 220 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 130 Institutional Trades Total Inst.Trades: 422 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $2.18M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.99M Avg Closing Trade (30 D): $2.22M Avg Closing Trade (90 D): $2.08M Avg Closing Volume: 390.25K     News Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.21 $-.01 $-.06 Diluted EPS $-.21 $-.01 $-.06 Revenue $ 246.03M $ 71.54M $ 60.12M Gross Profit $ $ $ Net Income / Loss $ -32M $ -1.93M $ -9.22M Operating Income / Loss $ -9.82M $ 4.48M $ -3.09M Cost of Revenue $ $ $ Net Cash Flow $ 1.58M $ .85M $ -13.18M PE Ratio